EPRIL Plus cpr 20/6 mg 100 pce
7680564800037
CH-56480
C09BA02
02.07.2.
Reimbursement limitations:
EPRILPLUS
Uniquement pour les patients qui sont déjà traités avec ce médicament.
1 / 3
google
Details
- Product number
- 5648001
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- Tablette: enalaprili maleas 20 mg, hydrochlorothiazidum 6 mg, natrii hydrogenocarbonas corresp. natrium 2.74 mg, lactosum monohydricum 118.2 mg, maydis amylum, talcum, magnesii stearas, pro compresso.
Articles (1)
Epril Plus, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
TAB
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
TAB
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
TAB
|
- | Substance | HNIDK |
|
TAB
|
2.74 MG | Substance | HBESI |
|
TAB
|
118.2 MG | Substance | HBESI |
|
TAB
|
- | Substance | HNIDK |
|
TAB
|
- | Substance | HNIDK |
|
TAB
|
- | Substance | HNIDK |
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 56480
- Drug name
- Epril Plus, Tabletten
- Galenic form
- TAB
- ATC Code
- C09BA02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 17/02/2004
- Authorization expiration date
- 01/09/2025
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EPRIL Plus cpr 20/6 mg 100 pce
- Description (DE)
- EPRIL Plus Tabl 20/6 mg 100 Stk
- Market launch
- 17/02/2004
- Market withdrawal
- 01/09/2025
- Narcotic (BTM)
- No